ACE-R |
Addenbrooke’s Cognitive Examination-Revised |
AD |
Alzheimer’s Disease |
ADNI |
Alzheimer’s Disease Neuroimaging Initiative |
APOE |
Apolipoprotein E |
CBS |
Cambridge Brain Sciences |
CES-D |
Centre for Epidemiological Studies Depression Scale |
CSN |
Canadian Stroke Network |
DTI |
Diffusion Tensor Imaging |
DWI |
Diffusion-Weighted Imaging |
Extended-CATCH |
CT and MRI in the Triage of TIA and minor Cerebrovascular events to identify High-risk patients |
GTP-RAB5 |
Guanine trinucleotide-bound Ras-Related Protein in Brain 5 |
IQCODE |
Informant Questionnaire on Cognitive Decline in the Elderly |
MCI |
Mild Cognitive Impairment |
MMSE |
Mini-Mental State Examination |
MoCA |
Montreal Cognitive Assessment |
MRI |
Magnetic Resonance Imaging |
MTA |
Mesial Temporal Atrophy |
NIHSS |
National Institutes of Health Stroke Scale |
NINDS |
National Institute of Neurological Disorders and Stroke |
OXVASC |
Oxford Vascular Study |
PET |
Positron Emission Tomography |
PREVENT |
Predementia Neuroimaging of Transient Ischemic Attack |
RIN3 |
Ras And Rab Interactor 3 |
STROKOG |
Stroke and Cognition consortium |
SVD |
Small Vessel Disease |
TCI |
Transient cognitive impairment |
TIA |
Transient Ischemic Attack |
TICSm |
Telephone Interview of Cognitive Status |
T-MoCA |
Telephone Montreal Cognitive Assessment |
TMT-B |
Trail Making Test-B |
VCI |
Vascular Cognitive Impairment |
WMH |
White Matter Hyperintensities |